Company: Ferring International
Job title: Therapeutic Area Head, GI & Liver Disease
Bryan Fuchs is Therapeutic Area Head for GI & Liver Disease at Ferring Pharmaceuticals.
Dr. Fuchs received his PhD in Biology from Saint Louis University examining the role of glutamine transporters in hepatocellular carcinoma (HCC) growth and survival. He completed a postdoctoral fellowship in the Division of Surgical Oncology at the Massachusetts General Hospital Cancer Center studying the role of epidermal growth factor (EGF) in the development of liver fibrosis and HCC. He is currently an Assistant Professor of Surgery at Harvard Medical School where his lab focuses on the identification of molecular pathways involved in liver fibrosis, and the analysis of anti-fibrotic therapies. More recent work has focused on the development of novel molecular imaging strategies to quantify collagen and lysyl oxidase-mediated collagen cross-linking as non-invasive means to monitor fibrosis progression, prognosticate outcomes, and measure response to therapy.